Home
Add Document
Sign In
Create An Account
SC04.02 Management of Resistance to EGFR Tyrosine Kinase Inhibitors
Recommend Documents
No documents
SC04.02 Management of Resistance to EGFR Tyrosine Kinase Inhibitors
Download PDF
36 downloads
0 Views
282KB Size
Report
Comment
regulation of
MED12
((Mediator Complex Subunit 12) have been proposed as mechanisms of EMT. Then, How are we able to cope with these resistance?
S82
Ref.
Journal of Thoracic Oncology
Pts.
3
81
4 5 6 7 8
50 79 28 151 70
Mean age
T1: T2
72
41: 41
74.1 74.8 82 73.9 83
30: 42: 12: 91: 39:
21 37 17 60 31
Total dose (GyRBE)/ fractions 59.4-95.4/ 9-18 72/ 9 52.8-60/ 4 52.8-72/ 4-9 36-50/ 1 28-50/ 1
Vol. 12 No. 1S
F/U (months)
5-yr local control
5-yr causespeciļ¬c survival
5-yr overall survival
Toxicity grade 3
×
Report "SC04.02 Management of Resistance to EGFR Tyrosine Kinase Inhibitors"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
×
Sign In
Email
Password
Remember me
Forgot password?
Sign In
Our partners will collect data and use cookies for ad personalization and measurement.
Learn how we and our ad partner Google, collect and use data
.
Agree & close